The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124749632 12474963 2 F 20160620 20160617 20160704 EXP DE-MLMSERVICE-20160531-0298541-1 DE-ACCORD-041509 ACCORD RACHOW T, DORNAUS S, SAYER HG, HERMANN B, HOCHHAUS A, VON LILIENFELD-TOAL M. CASE REPORT: FALSE POSITIVE ELEVATED SERUM-GALACTOMANNAN LEVELS AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION CAUSED BY ORAL NUTRITIONAL SUPPLEMENTS.CLINICAL CASE REPORTS. 2016; 4(5):505-508. 69.00 YR M Y 0.00000 20160704 OT DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124749632 12474963 1 PS ETOPOSIDE. ETOPOSIDE 1 U 74513
124749632 12474963 2 SS DOXORUBICIN DOXORUBICIN 1 SIX CYCLES Y 200750109
124749632 12474963 3 SS CYTARABINE/CYTARABINE HYDROCHLORIDE/CYTARABINE OCFOSFATE CYTARABINE 1 U 200750121
124749632 12474963 4 SS PREDNISOLONE. PREDNISOLONE 1 SIX CYCLES Y 0
124749632 12474963 5 SS RITUXIMAB RITUXIMAB 1 SIX CYCLES Y 0
124749632 12474963 6 SS CYCLOPHOSPHAMIDE/CYCLOPHOSPHAMIDE MONOHYDRATE CYCLOPHOSPHAMIDE 1 SIX CYCLES Y 0
124749632 12474963 7 SS VINCRISTINE VINCRISTINE 1 SIX CYCLES Y 0
124749632 12474963 8 SS THIOTEPA. THIOTEPA 1 U 0
124749632 12474963 9 SS MELPHALAN MELPHALAN 1 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124749632 12474963 1 Non-Hodgkin's lymphoma
124749632 12474963 2 Non-Hodgkin's lymphoma
124749632 12474963 3 Non-Hodgkin's lymphoma
124749632 12474963 4 Non-Hodgkin's lymphoma
124749632 12474963 5 Non-Hodgkin's lymphoma
124749632 12474963 6 Non-Hodgkin's lymphoma
124749632 12474963 7 Non-Hodgkin's lymphoma
124749632 12474963 8 Non-Hodgkin's lymphoma
124749632 12474963 9 Non-Hodgkin's lymphoma

Outcome of event

Event ID CASEID OUTC COD
124749632 12474963 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
124749632 12474963 Acute kidney injury
124749632 12474963 Aspergillus test positive
124749632 12474963 Catheter site infection
124749632 12474963 Cough
124749632 12474963 Decreased appetite
124749632 12474963 Diarrhoea
124749632 12474963 Dyspnoea
124749632 12474963 Escherichia test positive
124749632 12474963 Food contamination
124749632 12474963 Herpes simplex
124749632 12474963 Mucosal inflammation
124749632 12474963 Neutropenia
124749632 12474963 Off label use
124749632 12474963 Staphylococcus test positive
124749632 12474963 Stomatitis
124749632 12474963 Tumour lysis syndrome
124749632 12474963 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found